Treatment

INCB099280, Adagrasib clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingPhase I and Phase II (Integrated)- Other
A Phase 1 Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation
This study is looking at a new combination of medicines, INCB099280 and adagrasib, for adults with advanced solid cancers. These cancers have a specific gene change called 'KRASG12C'. We want to see how safe this combination is and if it helps control the cancer.
For: Advanced Solid Tumors Harboring a KRASG12C Mutation
Italy · France · Spain